The FDA sidelined Operation Warp Speed’s idea to halve doses of Moderna’s COVID-19 vaccine to expedite the vaccine rollout process, saying there is not enough data available to support this measure.
Moderna increased the minimum number of COVID-19 vaccines it expects to produce in 2021 by 20 percent to 600 million, the drugmaker said Jan. 4.
The U.S. likely won’t authorize AstraZeneca’s COVID-19 vaccine for emergency use until April, Operation Warp Speed Chief Moncef Slaoui, PhD, said in a Politico report.
China granted authorization to Sinopharm’s COVID-19 vaccine Dec. 31, approving its first state-developed COVID-19 vaccine for use in the general public.
The United Kingdom became the first country to grant emergency use authorization for the COVID-19 vaccine developed by AstraZeneca and the University of Oxford.
More articles on surgery centers:
Ohio health system acquires surgery center for $21M
2 Texas health systems suspend surgeries, others don’t
Stryker’s ASC-focused business: 3 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.